Boehringer Ingelheim

This project focused on CMO Clinical Manufacturing Facility Transfer lab and phase 1  covered 15,000 m² Land was implemented in 2012-2016, phase 2 covered 2,6000 m² Land arew as implemented from 2018 and underway.

NE's scope of work for this project are:

• CD / BD / DD /Procurement/CM Phase 1 

• Q&V – Phase 1 

• FS/ BD/ DD completed– Phase 2 

• Procurement Support / Qualification - ongoing
  

Highlights  for this project are:

• Single Use Technology mAb  

• Flexibility 

• Expandable Stepwise according to Market Trend 

• Aseptic Filling with isolator technology 

• Lyo: Reserved